Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren's syndrome

Arthritis and Rheumatism

Volumn 40, Issue 1, 1997, Pages 87-97

  Kong, Liping ^a   Ogawa, Noriyoshi ^a   Nakabayashi, Toru ^a   Liu, George T ^a   D'Souza, Errol ^a   Mcguff, H Stan ^a   Guerrero, Daniel ^a   Talal, Norman ^a   Dang, Howard ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND DISEASE; SJOEGREN SYNDROME;

ANTIGENS, CD95; APOPTOSIS; DNA FRAGMENTATION; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 0031028533     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400113     Document Type: Article

References (57)

1. Feind C: The head and neck. In, Lymphatics in Cancer. Edited by C Haagen, C Feind, F Herter, Slanetz CA Jr, Weinberg JA. Philadelphia, WB Saunders, 1972
2. Fox R, Kang H-I, Ando D, Abrams J, Pisa E: Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 152:5532-5539, 1994
3. Daniels T, Talal N: Diagnosis and differential diagnosis of Sjögren's syndrome. In: Sjögren's syndrome: clinical and immunological aspects. Talal N, Moutsopoulos HM, Kassan SS, eds. Berlin, Springer-Verlag, 1987
4. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima SI, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen fas can mediate apoptosis. Cell 66:233-243, 1991
5. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dheim J, Trauth BC, Ponsting H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J Biol Chem 267:10709-10715, 1992
6. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor for tumor necrosis factor. J Exp Med 169:1747-1756, 1989
7. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell 76:969-976, 1994
8. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178, 1993
9. Theofilopoulos AN, Dixon FJ: Murine models of systemic lupus erythematosus. Adv Immunol 37:269-390, 1987
10. Miyasaka N, Nakamura T, Russell IJ, Talal N: Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Irnmunopathol 31:109-117, 1984
11. Chu JL, Drappa J, Parnassa A, Elkon K: The defect in fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J Exp Med 178:723-730, 1993
12. Wu J, Zhou T, He J, Mountz JD: Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 178:461-468, 1993
13. Fisher GH, Rosenberg FJ, Straus S, Dale J, Middelton L, Lin A, Strober W, Lenardo M, Puck J: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946, 1995
14. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP: Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347-1349, 1995
15. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S, Drosos AA, Ehrenfeld M, Hatron PY, Hay EM, Isenberg DA, Janin A, Kalden JR, Kater L, Konttinen YT, Maddison PJ, Maini RN, Manthorpe R, Meyer O, Ostuni P, Pennec Y, Prause JU, Richards A, Sauvezie B, Schiødt M, Sciuto M, Scully C, Shoenfeld Y, Skopouli FN, Smolen JS, Snaith ML, Tishler M, Todesco S, Valesini G, Venables PJW, Wattiaux MJ, Youinou P: Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340-347, 1993
16. Chisholm DM, Mason DK: Labial salivary gland biopsy in Sjögren's syndrome. J Clin Pathol 21:656-660, 1968
17. Gavrieli Y, Sherman Y, Ben-Sasson S: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
18. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
19. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD: Protection of fas-mediated apoptosis by a soluble form of the fas molecule. Science 263:1759-1762, 1994
20. Moran A, Turner R: Secretagogue-induced RVD in HSY cells is due to K+ channels activated Ca+2 and protein kinase C. Am J Physiol Cell Physiol 34:C1405-C1411, 1993
21. Patton L, Pollack S, Wellner R: Responsiveness of a human parotid epithelial cell line (HSY) to autonomic stimulation: muscarinic control of K+ transport. In Vitro Cell Dev Biol Anim 27A:779-785, 1991
22. Nicoletti I, Migliorati G, Pagliacci M, Grigani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279, 1991
23. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456, 1995
24. Richardson BC, Lalwani ND, Johnson KJ, Marks RM: Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol 24:2640-2645, 1994
25. Miyawaki T, Vehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N: Differential expression of an apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 149:3753-3758, 1992
26. Nunez G, Merino R, Grillot D, González-Garcia M: Bcl-2 and bcl-x: regulatory switches for lymphoid death and survival. Immunol Today 15:582-587, 1994
27. Sarada K: Histopathological studies of the lacrimal gland in Sjögren's syndrome. Report 3. Electron microscopy of the changes of intralobular ducts. Nippon Ganka Gakkai Zasshi 86:1025-1042, 1982
28. Kong LP, Fei PF, Gong YH: A histopathologic study on lacrimal glands in Sjögren's syndrome. Chung Hua Yen Ko Tsa Chih 30:434-436, 1994
29. Kobayashi N, Hamamoto Y, Yamamoto N: Is TNF involved in the progression of AIDS? Virus Genes 4:183-190, 1990
30. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L: Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182:1223-1230, 1995
31. Hiramatsu N, Hayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, Kamada T: Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354-1359, 1994
32. Strober W, Ehrhardt RO: Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75:203-205, 1993
33. Cheng W, Li B, Kajstura J, Li P, Wolin M, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P: Stretch-induced programmed myocyte cell death. J Clin Invest 96:2247-2259, 1995
34. Cohen PL, Eisenberg RA: Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243-269, 1991
35. Mysler E, Bini P, Drappa J, Ramos P, Friedman S, Krammer PH, Elkon KB: The apoptosis-1/fas protein in human systemic lupus erythematosus. J Clin Invest 93:1029-1034, 1994
36. Ohsako S, Hara M, Harigai M, Fukasawa C, Kashiwazaki S: Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin Immunol Immunopathol 73:109-114, 1994
37. Amasaki Y, Kobayashi S, Takeda T, Ogura N, Jodo S, Nakabayashi T, Tsutsumi A, Fujisaku A, Koike T: Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Clin Exp Immunol 99:245-250, 1995
38. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 38:485-491, 1995
39. Firestein GS, Yeo M, Zavifler NJ: Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96:1631-1638, 1995
40. Itoh N, Nagata S: A novel protein domain required for apoptosis. J Biol Chem 268:10932-10937, 1993
41. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84:1201-1208, 1994
42. Weller M, Malipiero U, Aguzzi A, Reed JC, Fontana A: Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest 95:2633-2643, 1995
43. Strasser A, Harris AW, Von Boehmer H, Cory S: Positive and negative selection of T cells in T cell receptor transgenic mice expressing a bcl-2 transgene. Proc Natl Acad Sci U S A 91:1376-1380, 1994
44. Ogawa N, Dang H, Talal N: Apoptosis and autoimmunity. J Autoimmun 8:1-20, 1995
45. Taga K, Cherney B, Tosato G: IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int Immunol 5:1599-1608, 1993
46. Taga K, Chretien J, Cherney B, Diaz L, Brown M, Tosato G: Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells. J Clin Invest 94:251-260, 1994
47. Vella AT, McCormack JE, Linsley PS, Kappler JW, Marrack P: Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2:261-270, 1995
48. Liu YJ, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, Maclennan ICM: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21:1905-1910, 1991
49. Sumimoto S-I, Heiko T, Kanazashi S-I, Shintaku N, Jung E-Y, Hata D, Katamura K, Mayumi M: Involvement of LFA-1/intracellular adhesion molecule-1-dependent cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking. J Immunol 153:2488-2496, 1994
50. Talal N, Bunim JJ: The development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 36:529-540, 1964
51. Anderson L, Talal N: The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clin Exp Immunol 9:199-221, 1971
52. Kondo E, Yoshino T, Yamadori I, Matsuo Y, Kawasaki N, Minowada J, Akagi T: Expression of bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas. Am J Pathol 145:330-337, 1994
53. Mapara M, Bargou R, Zugck C, Döhner H, Ustaoglu F, Jonker R, Krammer P, Dörken B: APO-1-mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol 23:702-708, 1993
54. Alpert S, Kang H-I, Weissman I, Fox RI: Expression of granzyme A in salivary gland biopsies from patients with primary Sjögren's syndrome. Arthritis Rheum 37:1046-1054, 1994
55. Glickstein LJ, Huber BT: Karoushi: death by overwork in the immune system. J Immunol 155:522-523, 1995
56. Tabi Z, McCombe P, Pender M: Apoptotic elimination of Vβ8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of Vβ8.2+ encephalogenic T cells. Eur J Immunol 24:2609-2617, 1994
57. Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, Wekerle H, Lassmann H: Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: evidence for programmed cell death as a mechanism of control of inflammation in the brain. Am J Pathol 143:446-452, 1993